These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 9467849)

  • 1. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dynamics and telomerase activity in in vitro immortalised human cells.
    Bryan TM; Reddel RR
    Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere length dynamics in telomerase-positive immortal human cell populations.
    Bryan TM; Englezou A; Dunham MA; Reddel RR
    Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
    Kang MK; Guo W; Park NH
    Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere maintenance by recombination in human cells.
    Dunham MA; Neumann AA; Fasching CL; Reddel RR
    Nat Genet; 2000 Dec; 26(4):447-50. PubMed ID: 11101843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activation in human fibroblasts during escape from crisis.
    Montalto MC; Phillips JS; Ray FA
    J Cell Physiol; 1999 Jul; 180(1):46-52. PubMed ID: 10362016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.
    Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ
    Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
    Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
    Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells.
    Jones CJ; Soley A; Skinner JW; Gupta J; Haughton MF; Wyllie FS; Schlumberger M; Bacchetti S; Wynford-Thomas D
    Exp Cell Res; 1998 May; 240(2):333-9. PubMed ID: 9597006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.